Alli Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Conditions:   Type 2 Diabetes;   Obesity Interventions:   Other: Weight Management Program (WMP);   Other: Traditional care;   Drug: Phentermine / Topiramate Extended Release Oral Capsule;   Drug: naltrexone/bupropion extended-release;   Drug: liraglutide 3.0 mg;   Drug: Orlistat Sponsor:   The Cleveland Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials

EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Conditions:   Type 2 Diabetes;   Obesity Interventions:   Other: Weight Management Program (WMP);   Other: Traditional care;   Drug: Phentermine / Topiramate Extended Release Oral Capsule;   Drug: naltrexone/bupropion extended-release;   Drug: liraglutide 3.0 mg;   Drug: Orlistat Sponsor:   The Cleveland Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2020 Category: Research Source Type: clinical trials